Researchers develop ‘Trojan horse’ chemo drug delivery system
Northwestern University researchers have developed a drug delivery system that can disguise chemotherapy...
Focus:
-
![Recursion raises $121m to support AI-based drug discovery]()
Recursion secures funds to support AI-based drug discovery
-
![AI in pharma supply chains]()
Aera: automating pharma supply chain management
-
![New CRISPR study offers hope for potential HIV cure]()
CRISPR study offers hope for potential HIV cure
-
![AI drug failures]()
Predicting drug flops with AI
-
![powder vial filling sealing machines]()
Snowbell Machines: Experts in pharma powder and liquid filling machinery
-
![US CRISPR patents]()
USPTO reverses decision regarding interfering CRISPR patents
Most Read
Company A-Z
Latest Content
Researchers develop ‘Trojan horse’ chemo drug delivery system
Northwestern University researchers have developed a drug delivery system that can disguise chemotherapy drugs as fat, meaning that tumours readily consume them, the drugs are then activated to suppress tumour growth and eventually the tumour dies.
Researchers develop genomic barcode to track immune cells
A Garvan Institute of Medical Research team in Australia has created a genomic barcode to identify immune cells that recognise and act against cancer from within a patient’s immune system.
Critical Contamination Control Specialists
Controlling contamination and cross-contamination at or near floor level is an essential and fundamental part of any integrated risk management policy.
Recursion secures funds to support AI-based drug discovery
Artificial intelligence (AI) drug discovery firm Recursion Pharmaceuticals, has secured $121m in a series C funding round led by the Scottish Mortgage Investment Trust.
Measurement Uncertainty in GxP Temperature Mapping
In the real world of GMP, GDP and GLP, is expressing measurement uncertainty in mapping (and not just in calibration) an overkill, or there is some reason to it?
Aera: automating pharma supply chain management
Aera believes its AI-based platform can support pharma companies through normal supply chain challenges, as well as manage larger disruption issues, such as Brexit. The company’s chief marketing officer Ram Krishnan explains how and why AI can support pharma companies in these respects.
Merck and Skyhawk Therapeutics sign collaboration agreement
Merck has signed a strategic collaboration agreement with Skyhawk Therapeutics to use its SkySTAR technology to develop drug candidates for patients with neurodegenerative diseases and cancer.
CRISPR study offers hope for potential HIV cure
A study by US researchers has used a genetic editing technology to eliminate replication-competent HIV-1 DNA from the genomes of living animals, offering hope for a potential cure in humans.
The Antibody Dependent Cell Mediated Cytotoxicity
The medical indications of therapeutic antibodies (tAb) have been growing. The antibody dependent cell-mediated cytotoxicity (ADCC) is a mechanism of immune defence attributed to the mode of action of several tAb, in particular, tumour cell targeting.
Getting Acquainted with the XRF Theory
This white paper provides a general introduction to X-ray Fluorescence (CRF) spectrometry and XRF analysis. It explains how a spectrometer works and how XRF analysis is achieved.
Latest News
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.
Close
Close
Close
Go Top
